Æterna Zentaris (AEZS) Reports Article on Final Data from Phase 1 Zoptarelin Doxorubicin in Prostate Cancer
Tweet Send to a Friend
Aeterna Zentaris Inc. (NASDAQ: AEZS) today announced that an article on final data for the Phase 1 portion of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
